azathioprine has been researched along with Stroke in 8 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the risk of long-term cardiovascular and metabolic outcomes and all-cause mortality in patients with pemphigus managed by rituximab compared with those receiving treatment with first-line corticosteroid-sparing agents (azathioprine and mycophenolate mofetil [MMF])." | 4.31 | Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. ( Kridin, K; Ludwig, RJ; Mruwat, N, 2023) |
| "Arterial ischemic stroke is rare in childhood." | 1.51 | Recurrent arterial ischemic stroke with good response to mycophenolate mofetil. ( Dehoorne, J; Herregods, N; Mondelaers, V; Van Coster, R; Van Driessche, B; Verhelst, H; Verloo, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kridin, K | 3 |
| Mruwat, N | 3 |
| Ludwig, RJ | 3 |
| Choi, MY | 1 |
| Li, D | 1 |
| Feldman, CH | 1 |
| Yoshida, K | 1 |
| Guan, H | 1 |
| Kim, SC | 1 |
| Everett, BM | 1 |
| Costenbader, KH | 1 |
| Van Driessche, B | 1 |
| Verloo, P | 1 |
| Herregods, N | 1 |
| Mondelaers, V | 1 |
| Dehoorne, J | 1 |
| Van Coster, R | 1 |
| Verhelst, H | 1 |
| Rodrigues, M | 1 |
| Amaral, D | 1 |
| Barreira, JL | 1 |
| Brito, I | 1 |
| Mijajlovic, M | 1 |
| Mirkovic, M | 1 |
| Dackovic, J | 1 |
| Zidverc-Trajkovic, J | 1 |
| Sternic, N | 1 |
| Malik, MA | 1 |
| Zia-ur-Rehman, M | 1 |
| Nadeem, MM | 1 |
| Chaudhry, FR | 1 |
| Qureshi, AA | 1 |
| Nawaz, M | 1 |
| Malik, H | 1 |
| Patterson, SL | 1 |
| LaMonte, MP | 1 |
| Mikdashi, JA | 1 |
| Haines, ST | 1 |
| Hursting, MJ | 1 |
| Ozdogu, H | 1 |
| Boga, C | 1 |
| Kizilkilic, E | 1 |
| Yeral, M | 1 |
| Kozanoglu, I | 1 |
| Karatas, M | 1 |
1 review available for azathioprine and Stroke
| Article | Year |
|---|---|
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Hu | 2006 |
7 other studies available for azathioprine and Stroke
| Article | Year |
|---|---|
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Topics: Azathioprine; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunosuppres | 2023 |
Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
Topics: Adult; Azathioprine; Cardiovascular Diseases; Cause of Death; Coronary Artery Bypass; Cyclophosphami | 2021 |
Recurrent arterial ischemic stroke with good response to mycophenolate mofetil.
Topics: Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; | 2019 |
Childhood polyarteritis nodosa presenting as stroke and arterial hypertension.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Antirheumatic Agents; Azathioprine; Child; Cycloph | 2014 |
Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Diagnosis, Differential; Electroencephalography; Encep | 2010 |
Childhood primary angiitis of the central nervous system.
Topics: Adolescent; Anti-Inflammatory Agents; Anticoagulants; Azathioprine; Brain Ischemia; Child; Child, Pr | 2012 |
A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathio | 2007 |